Valuation: Boston Scientific Corporation

Market Cap 63.58B 55.07B 52.08B 47.15B 88.48B 6,099B 89.15B 621B 239B 3,092B 239B 234B 9,862B P/E 2026 *
16.6x
P/E 2027 * 17.3x
Enterprise Value 72.3B 62.63B 59.22B 53.62B 101B 6,936B 101B 707B 272B 3,517B 272B 266B 11,216B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.1x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
1 day-2.62%
1 week-2.47%
Current month-9.17%
1 month-15.36%
3 months-6.18%
6 months-36.54%
Current year-53.99%
1 week 42.78
Extreme 42.78
45.15
1 month 42.78
Extreme 42.78
52.56
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
105.65
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 2011-10-31
Director of Finance/CFO 52 2025-06-29
Chief Tech/Sci/R&D Officer - 2009-08-31
Director TitleAgeSince
Chairman 61 2016-05-02
Director/Board Member 74 2014-02-28
Director/Board Member 74 2016-04-14
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 Buy

Director

2,040 0.0001%
8/11/26 Other

Controller/Auditor

2,930 0.0002%
8/10/26 Other

Chief Financial Officer

9,908 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-2.62%-2.47%-56.07%-17.07% 63.58B
+4.61%+6.36%+35.18%+24.41% 237B
+3.01%+2.01%+11.04%-17.98% 147B
-0.21%+7.71%-13.09%+27.62% 133B
-0.31%-0.33%-18.70%-15.74% 49.95B
+0.26%-1.13%+12.74%+17.13% 49.42B
+2.36%+2.33%+19.61%+29.64% 42.37B
+1.73%+3.52%+39.48%+51.23% 40.98B
+2.89%+3.80%-15.40%+57.81% 32.82B
+6.76%+5.32%+120.26%+52.10% 33.57B
Average +1.73%+0.14%+13.51%+20.92% 83.03B
Weighted average by Cap. +1.97%+2.15%+12.45%+15.42%

Financials

2026 *2027 *
Net sales 21.32B 18.47B 17.47B 15.81B 29.68B 2,046B 29.9B 208B 80.19B 1,037B 80.1B 78.32B 3,308B 22.3B 19.32B 18.27B 16.54B 31.04B 2,139B 31.27B 218B 83.87B 1,085B 83.77B 81.92B 3,459B
Net income 3.8B 3.29B 3.11B 2.81B 5.28B 364B 5.32B 37.11B 14.28B 185B 14.26B 13.94B 589B 3.68B 3.19B 3.01B 2.73B 5.12B 353B 5.16B 35.98B 13.84B 179B 13.83B 13.52B 571B
Net Debt 8.73B 7.56B 7.15B 6.47B 12.15B 837B 12.24B 85.3B 32.82B 424B 32.78B 32.05B 1,354B 5.47B 4.74B 4.48B 4.06B 7.61B 525B 7.67B 53.48B 20.58B 266B 20.55B 20.1B 849B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
26-09-15 US$43.87 -2.62% 16,015,363
26-09-14 US$45.05 +4.82% 20,521,670
26-09-11 US$42.98 -0.28% 26,986,789
26-09-10 US$43.10 -4.14% 22,690,902
26-09-09 US$44.96 -0.04% 17,979,923
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
43.87USD
Average target price
62.00USD
Spread / Average Target
+41.33%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!